Clinical Trial

Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients

Study acronym: FLEX5 project
Recruiting
View on ClinicalTrials.gov →
Summary
This study examines adults with COL5A gene mutations to understand why some develop aortic aneurysms while others do not. Participants provide a small skin biopsy, and researchers analyze fibroblasts to evaluate collagen production, extracellular matrix organization, and connective-tissue signaling pathways. The goal is to identify biological differences that may explain variable vascular risk and support future personalized monitoring and treatment strategies.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-03
Trial Details
NCT Number NCT07282717
Lead Sponsor IRCCS Policlinico S. Donato
Conditions Mutations Affecting the COL5A Gene, Aneurysm Aortic
Enrollment 20 participants
Start Date 2026-06-24
Primary Completion 2028-01 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02